1
项与 HIV 1 antigen expanded specific T cell(NIH) 相关的临床试验IGHID 1320 - A Phase I Study to Evaluate the Safety, Immunologic, and Virologic Responses of HIV-1 Antigen Expanded Specific T Cell Therapy (HXTC) as a Therapeutic Strategy in HIV-Infected Individuals Started on Antiretroviral Therapy During Acute and Chronic Infection
This is a phase 1, single-site study is to evaluate the safety and immunologic and virologic efficacy of ex vivo expanded HIV-1 multi-antigen specific T-cell (HXTC) therapy in HIV-infected individuals with viral suppression on antiretroviral therapy (ART).
100 项与 HIV 1 antigen expanded specific T cell(NIH) 相关的临床结果
100 项与 HIV 1 antigen expanded specific T cell(NIH) 相关的转化医学
100 项与 HIV 1 antigen expanded specific T cell(NIH) 相关的专利(医药)
100 项与 HIV 1 antigen expanded specific T cell(NIH) 相关的药物交易